OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
January 02, 2011
Top priorities for manufacturers include user fees, new health initiatives, and regulatory compliance.
December 02, 2010
Republican gains in Congress create uncertainty for healthcare reform, drug regulation, and biomedical research.
November 02, 2010
A new center may provide evidence for improving care, but could discourage coverage of treatments.
October 02, 2010
President Obama and HHS eye innovation and countermeasures to protect public health.
September 02, 2010
Weighing the pros and cons of REMS for bringing risky products to market.
August 02, 2010
Fallout escalates from McNeil recall and Genzyme shortages as regulators review oversight.